Mankind Pharma forays into pet food category
Advertisement
New Delhi: Pet foods startup Dogsee Chew on Wednesday said it has raised Rs 50 crore in Series A funding round from Mankind Pharma along with existing investor, Sixth Sense Ventures. The investment in the firm that offers 100 percent vegetarian dog treats marks Mankind Pharma's entry into the pet food category, Dogsee Chew said in a statement.
Sixth Sense Ventures had also earlier participated in the company's pre-series A funding in November 2021, it added.
The funds will be primarily used towards brand building, R&D, and building a strong distribution network, the company said, adding it currently exports its products to over 30 countries.
The funds will be primarily used towards brand building, R&D, and building a strong distribution network, the company said, adding it currently exports its products to over 30 countries.
Commenting on the fundraise, Dogsee Chew Founder Bhupendra Khanal said, "Mankind Pharma has an established history of creating highly successful consumer products. Having the backing of such a giant is a huge vote of confidence for us and we look forward to learning from their expertise."
On its investment, Mankind Pharma Chief Operations Officer Arjun Juneja said, "The trust that people have shown in Dogsee Chew has strengthened our confidence to invest in a brand that is true to its nature. Mankind has always believed in innovation and, with brands like Dogsee Chew that are innovative and young, we see the future of India."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.